Acute Decompensated Heart Failure Adhf clinical trials

Explore recruiting acute decompensated heart failure adhf clinical trials.

Recruiting acute decompensated heart failure adhf studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acute Decompensated Heart Failure Adhf trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Effects of continued administration of empagliflozin in patients with heart failure on active SGLT2 inhibitor treatment admitted for acute decompensated heart failure

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage C (SEISMiC-C)

Poland, Czechia, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Acute Decompensated Heart Failure Adhf trials by city

Acute Decompensated Heart Failure Adhf clinical trials

Recruiting acute decompensated heart failure adhf studies right now

POCUS-Guided Diuresis for Decompensated Heart Failure

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

Safety and Performance Evaluation of the Nephronyx System for the Treatment of Patients With ADHF

Mobile Education System to Improve Disease Knowledge, Self-efficacy and Quality of Life in Patients With Heart Failure

Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure

Using an Intervention Adapted to the Health Literacy Level to Improve Adherence to Medical Recommendations

Effects of Continued Administration of Empagliflozin in Patients With Heart Failure on Active SGLT2 Inhibitor Treatment Admitted for Acute Decompensated Heart Failure

Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions

The Effect of Dapagliflozin on Patients With Cardiomyopathy

Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure

Reprieve System Pilot Study

The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

Also recruiting in Europe

Effects of continued administration of empagliflozin in patients with heart failure on active SGLT2 inhibitor treatment admitted for acute decompensated heart failure

A Multicenter, Randomized, Placebo-Controlled, Parallel Group Trial on the Safety and Efficacy of Istaroxime for Cardiogenic Shock SCAI Stage C (SEISMiC-C)

Acute Decompensated Heart Failure Adhf trials by city

Other conditions